Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial.
The Lancet. Infectious diseases
View this publicationThe Lancet. Infectious diseases
View this publicationPLoS neglected tropical diseases
View this publicationBMJ open
View this publicationParasites & vectors
View this publicationMicroorganisms
View this publicationJournal of travel medicine
View this publicationPloS one
View this publicationScientific reports
View this publicationFrontiers in immunology
View this publicationPLoS neglected tropical diseases
View this publication